San Cristóbal Cancer Institute Now Offers Cutting-Edge SIGNA™ Architect Technology

San Cristóbal Cancer Institute is proud to announce the inauguration of the highly anticipated SIGNA™ Architect machine in June, marking a significant milestone in our commitment to providing state-of-the-art medical imaging technology to our patients. This revolutionary machine represents a leap forward in diagnostic capabilities, allowing for more accurate and detailed imaging that can greatly improve the effectiveness of cancer diagnoses and treatment planning. This technology will allow us to provide our new diagnostics service: MPMRI, or multiparametric magnetic resonance imaging, a powerful diagnostic tool used in various medical fields. It combines multiple MRI sequences to provide detailed information about different aspects of tissues and organs. MPMRI is commonly used for the detection, localization, staging, and monitoring of various conditions, including prostate cancer, breast cancer, liver diseases, neurological disorders, and musculoskeletal abnormalities. Its multi-dimensional approach enhances diagnostic accuracy and guides treatment decision-making.

MPMRI is a crucial tool in the management of prostate cancer patients. It offers multiple benefits throughout the patient journey. MPMRI aids in the detection and localization of suspicious lesions within the prostate gland, facilitating targeted biopsies. It plays a vital role in staging, accurately assessing tumor extent and involvement of adjacent structures. This information guides treatment planning, allowing for personalized approaches based on tumor characteristics. MPMRI is also valuable in active surveillance, monitoring disease progression over time. It helps identify significant changes and determines the need for intervention. Additionally, MPMRI assists in detecting tumor recurrence, enabling early identification and timely intervention. In summary, MPMRI enhances risk stratification, treatment decision-making, and patient outcomes in prostate cancer management.


The Value of SIGNA™ Architect Technology

The SIGNA™ Architect machine is a groundbreaking advancement in medical imaging that offers numerous benefits for patients and healthcare providers alike. Equipped with the latest-generation reconstruction engine, AIR™ Recon, this cutting-edge technology enables our team to capture cleaner and more precise images, enhancing the diagnostic accuracy and precision of our examinations. The high-resolution imaging produced by SIGNA™ Architect provides unparalleled clarity, allowing physicians to detect and analyze even the smallest abnormalities with exceptional precision. This level of detail is especially crucial in cancer diagnosis, where early detection and accurate assessment are key to successful treatment outcomes. Furthermore, the SIGNA™ Architect machine is equipped with innovative features such as AIR Touch™ and AIRx™*, intelligent workflows that streamline exam setup and testing processes. These advancements not only improve the efficiency of our staff but also enhance the overall patient experience, reducing waiting times and ensuring a more comfortable and convenient imaging procedure.




Expert Staff and Collaborative Approach

At San Cristóbal Cancer Institute, we take pride in our well-trained and experienced staff who are proficient in operating the SIGNA™ Architect machine. Our dedicated team of radiologists, technologists, and support personnel undergo rigorous training to ensure they are well-versed in the intricacies of this advanced technology. Working hand in hand with our highly skilled physicians, our staff combines technical expertise with clinical knowledge to provide comprehensive and accurate assessments. The collaborative approach between our referring physicians and our proficient staff guarantees that each patient receives the highest standard of care throughout their diagnostic journey.


Our Commitment to Excellence

San Cristóbal Cancer Institute is committed to continuously investing in cutting-edge technology to stay at the forefront of cancer care. The introduction of the SIGNA™ Architect machine is a testament to our unwavering dedication to delivering the best possible outcomes for our patients. By combining our exceptional staff with the innovative capabilities of the SIGNA™ Architect, we aim to provide a comprehensive and personalized approach to cancer diagnosis and treatment planning. Our focus on precision, accuracy, and patient-centric care remains unwavering as we harness the power of advanced medical imaging technology to optimize outcomes and improve the lives of those affected by cancer. “The introduction of the SIGNA™ Architect machine at San Cristóbal Cancer Institute represents a significant step in our commitment to delivering exceptional care to our patients. This state-of-the-art technology, coupled with our expert staff and renowned physicians, empowers us to provide accurate diagnoses and personalized treatment plans, ultimately leading to better patient outcomes,” explains Ana Cristina Muñoz, President at Grupo San Cristóbal. “As we embark on this new chapter, San Cristóbal Cancer Institute reaffirms its dedication to innovation, excellence, and the highest standard of care. We look forward to the immense positive impact that the SIGNA™ Architect machine will have on our patients’ lives, offering them the best possible chance in their fight against cancer,” she adds.